产品名称：Human FceR2 / CD23 Antibody (Lumiliximab, Research Use)
产品编号：NBR-0679
针对靶点：FceR2 / CD23
抗体药商品名：Lumiliximab
抗体药描述：Lumiliximab is a primatized, IgG1, anti-CD23 mAb that was studied in PBMCs of atopic patients and shown to reduce allergen-induced PBMC proliferation and levels of proinflammatory cytokines such as IL-1β, IL-5, and TNF-α. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: FCER2
Synonyms: CLEC4J; CD23; FCE2
Target Description: Low-affinity receptor for immunoglobulin E (IgE) and CR2/CD21. Has essential roles in the regulation of IgE production and in the differentiation of B-cells (it is a B-cell-specific antigen).
Ensembl: ENSG00000104921
Uniprot: P06734